Treatment-induced neoangiogenesis in cerebral arteriovenous malformations

Citation
U. Sure et al., Treatment-induced neoangiogenesis in cerebral arteriovenous malformations, CLIN NEUROL, 103(1), 2001, pp. 29-32
Citations number
16
Categorie Soggetti
Neurology
Journal title
CLINICAL NEUROLOGY AND NEUROSURGERY
ISSN journal
03038467 → ACNP
Volume
103
Issue
1
Year of publication
2001
Pages
29 - 32
Database
ISI
SICI code
0303-8467(200104)103:1<29:TNICAM>2.0.ZU;2-B
Abstract
We investigated the angiogenetic and proliferative activity of the endothel ium of 30 consecutive surgical cases of AVM treated at our institution by i mmunohistochemical detection of the PCNA, MIB-1, Flk-1 and VEGF antibodies. Endothelial positive immunostaining was observed in 87% of the cases for P CNA, in 20% for MIB-1, and in 80% for Flk-1. Of 22 individuals treated with incomplete embolization prior to surgery, 17 showed an expression of VEGF (77%), but only two of the eight patients (25%) who were treated without pr ior embolization exhibited such an immunoreaction (P = 0.0086). The prolife ration and growth of cerebral AVMs is documented by endothelial expression of PCNA and MIB-1. The statistically significantly higher expression of VEG F in partially obliterated (embolized) AVMs is most likely caused by transi ent regional hypoxia within the AVM nidus that mediates neoangiogensis. It points out the clinical relevance of a complete occlusion in order to avoid neovascularization associated with subsequent morbidity and mortality. (C) 2001 Elsevier Science B.V. All rights reserved.